Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NPS Pharmaceuticals
NPS Pharmaceuticals
Ten Top Biotech Merger and Partnership Candidates
Wall St 24/7
Fri, 03/14/14 - 10:53 am
M&A
biotech
Alkermes
Akorn
Auxilium
Cubist Pharmaceuticals
Hospira
Jazz Pharmaceuticals
Medivation
NPS Pharmaceuticals
Salix
United Therapeutics
Is NPS Pharmaceuticals The Next Alexion?
Seeking Alpha
Tue, 02/25/14 - 11:03 am
NPS Pharmaceuticals
Alexion
NPSP795
Gattex
NPS, Iroko show how companies can grow sales, not staff
Fierce Pharma
Fri, 02/14/14 - 01:01 pm
NPS Pharmaceuticals
Iroko Pharmaceuticals
Zorvolex
Gattex
NPS Pharma Finds Big Success In Tiny Markets
Investors.com
Fri, 02/14/14 - 12:00 pm
NPS Pharmaceuticals
Gattex
short bowel syndrome
Natpara
hypoparathyroidism
NPS Pharmaceuticals sees FY13 net global Gattex sales approx. $31.5M
Yahoo/Fly on the Wall
Wed, 01/8/14 - 09:27 am
Gattex
NPS Pharmaceuticals
revestive
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
biotech
Vertex Pharmaceuticals
Orexigen
Retrophin
Valeant Pharmaceuticals
Questcor
Biomarin
Merck
NeoStem
Amgen
Gilead Sciences
Vanda
Keryx
Peregrine Pharmaceuticals
CelSci
Regeneron
Cempra
Dendreon
Clovis Oncology
Halozyme
NPS Pharmaceuticals
NPS Pharma Commences Study on Pediatrics
Yahoo/Zacks.com
Fri, 01/3/14 - 11:50 am
pediatrics
NPS Pharmaceuticals
Gattex
short bowel syndrome
3 Biotech Stocks Spiking on Big Volume
TheStreet.com
Thu, 12/19/13 - 08:11 am
NPS Pharmaceuticals
Halozyme
Alexion
The Best Biotech CEO of 2013 is...
TheStreet.com
Tue, 12/17/13 - 08:49 am
biotech
Celgene
NPS Pharmaceuticals
Bristol-Myers Squibb
ONYX Pharmaceuticals
4 Healthcare Stock Stories Making Midweek Headlines
Wall St Cheat Sheet
Thu, 11/14/13 - 10:15 am
BAX 855
Baxter International
plecanatide
Synergy Pharmaceuticals
layoffs
Transcept
NPS Pharmaceuticals
Gattex
Top Biotech Stock Picks for Q4 2013: An Interview with the Senior Analyst at Oppenheimer & Company
Yahoo/Wall St Transcript
Sat, 09/14/13 - 10:38 am
Amgen
Celgene
ONYX Pharmaceuticals
Keryx
Pluristem Therapeutics
NPS Pharmaceuticals
The Run Isn't Over for This Booming Biotech
Motley Fool
Sun, 09/8/13 - 11:07 am
NPS Pharmaceuticals
NPS Pharmaceuticals Has A Billion Plus Blockbuster On Its Hands
Seeking Alpha
Tue, 08/13/13 - 10:55 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
NPS Pharmaceuticals Enrolls First Patient in Global Registry Designed to Characterize the Natural History of Hypoparathyroidism
Yahoo/BusinessWire
Thu, 08/1/13 - 08:41 am
NPS Pharmaceuticals
hypoparathyroidism
The Profitable Business of Developing Orphan Drugs
Motley Fool
Tue, 06/4/13 - 12:44 pm
orphan drugs
NPS Pharmaceuticals
Gattex
Soliris
Alexion
Genzyme
Renagel
Cerezyme
Fabrazyme
Sanofi
Can These Biotechs Continue to Climb?
Motley Fool
Tue, 04/16/13 - 12:04 pm
Regeneron
NPS Pharmaceuticals
Orphan Drug Is Headed Back to Its Parent: NPS Pharmaceuticals, Inc.
Insider Monkey
Sat, 03/23/13 - 10:05 am
NPS Pharmaceuticals
revestive
preotact
NPS Buys Back Rights to Gattex From Takeda to Spur Sales
Bloomberg
Tue, 03/19/13 - 11:06 am
NPS Pharmaceuticals
Takeda
Gattex
short bowel syndrome
NPS Pharmaceuticals Chief: Why 250k-a-Year Orphan Drug is Worth It
Y Charts
Sun, 02/3/13 - 11:35 am
Gattex
NPS Pharmaceuticals
short bowel syndrome
3 Drug Launches You Need to Know in 2013
Motley Fool
Wed, 01/16/13 - 11:18 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
Iclusig
Ariad
chronic myeloid leukemia
Pfizer
Eliquis
Bristol-Myers Squibb
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »